166 related articles for article (PubMed ID: 27071418)
1. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.
Toki S; Goleniewska K; Reiss S; Zhou W; Newcomb DC; Bloodworth MH; Stier MT; Boyd KL; Polosukhin VV; Subramaniam S; Peebles RS
Thorax; 2016 Jul; 71(7):633-45. PubMed ID: 27071418
[TBL] [Abstract][Full Text] [Related]
2. Progesterone amplifies allergic inflammation and airway pathology in association with higher lung ILC2 responses.
Trivedi S; Deering-Rice CE; Aamodt SE; Huecksteadt TP; Myers EJ; Sanders KA; Paine R; Warren KJ
Am J Physiol Lung Cell Mol Physiol; 2024 Jul; 327(1):L65-L78. PubMed ID: 38651968
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic functional defects of type 2 innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice.
Verhoef PA; Constantinides MG; McDonald BD; Urban JF; Sperling AI; Bendelac A
J Allergy Clin Immunol; 2016 Feb; 137(2):591-600.e1. PubMed ID: 26602165
[TBL] [Abstract][Full Text] [Related]
4. Rhinovirus C Infection Induces Type 2 Innate Lymphoid Cell Expansion and Eosinophilic Airway Inflammation.
Rajput C; Han M; Ishikawa T; Lei J; Goldsmith AM; Jazaeri S; Stroupe CC; Bentley JK; Hershenson MB
Front Immunol; 2021; 12():649520. PubMed ID: 33968043
[TBL] [Abstract][Full Text] [Related]
5. ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung.
Schuijs MJ; Png S; Richard AC; Tsyben A; Hamm G; Stockis J; Garcia C; Pinaud S; Nicholls A; Ros XR; Su J; Eldridge MD; Riedel A; Serrao EM; Rodewald HR; Mack M; Shields JD; Cohen ES; McKenzie ANJ; Goodwin RJA; Brindle KM; Marioni JC; Halim TYF
Nat Immunol; 2020 Sep; 21(9):998-1009. PubMed ID: 32747815
[TBL] [Abstract][Full Text] [Related]
6. STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33-driven type 2 immunopathology.
She L; Barrera GD; Yan L; Alanazi HH; Brooks EG; Dube PH; Sun Y; Zan H; Chupp DP; Zhang N; Zhang X; Liu Y; Li XD
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400692
[TBL] [Abstract][Full Text] [Related]
7. Neonatal hyperoxia promotes asthma-like features through IL-33-dependent ILC2 responses.
Cheon IS; Son YM; Jiang L; Goplen NP; Kaplan MH; Limper AH; Kita H; Paczesny S; Prakash YS; Tepper R; Ahlfeld SK; Sun J
J Allergy Clin Immunol; 2018 Oct; 142(4):1100-1112. PubMed ID: 29253513
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic sensing of allergen exposure by airway epithelium promotes type 2 immunity in the lungs.
Hayashi R; Srisomboon Y; Iijima K; Maniak PJ; Tei R; Kobayashi T; Matsunaga M; Luo H; Masuda MY; O'Grady SM; Kita H
J Allergy Clin Immunol; 2024 Mar; 153(3):793-808.e2. PubMed ID: 38000698
[TBL] [Abstract][Full Text] [Related]
9. Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation.
Cavagnero KJ; Badrani JH; Naji LH; Amadeo MB; Leng AS; Lacasa LD; Strohm AN; Renusch SR; Gasparian SS; Doherty TA
Front Immunol; 2021; 12():618807. PubMed ID: 33679760
[TBL] [Abstract][Full Text] [Related]
10. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Lo R; Howard E; Hurrell BP; Galle-Treger L; Painter JD; Lewis G; Soroosh P; Sharpe AH; Akbari O
Nat Commun; 2020 Aug; 11(1):3998. PubMed ID: 32778730
[TBL] [Abstract][Full Text] [Related]
11. HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation.
Wang Z; Yan C; Du Q; Huang Y; Li X; Zeng D; Mao R; Gurram RK; Cheng S; Gu W; Zhu L; Fan W; Ma L; Ling Z; Qiu J; Li D; Liu E; Zhang Y; Fang Y; Zhu J; Sun B
Cell Mol Immunol; 2023 Apr; 20(4):404-418. PubMed ID: 36823235
[TBL] [Abstract][Full Text] [Related]
12. IL-33trap is a novel IL-33-neutralizing biologic that inhibits allergic airway inflammation.
Holgado A; Braun H; Van Nuffel E; Detry S; Schuijs MJ; Deswarte K; Vergote K; Haegman M; Baudelet G; Haustraete J; Hammad H; Lambrecht BN; Savvides SN; Afonina IS; Beyaert R
J Allergy Clin Immunol; 2019 Jul; 144(1):204-215. PubMed ID: 30876911
[TBL] [Abstract][Full Text] [Related]
13. Iron controls the development of airway hyperreactivity by regulating ILC2 metabolism and effector function.
Hurrell BP; Sakano Y; Shen S; Helou DG; Li M; Shafiei-Jahani P; Kazemi MH; Sakano K; Li X; Quach C; Barbers R; Akbari O
Sci Transl Med; 2024 May; 16(746):eadk4728. PubMed ID: 38718131
[TBL] [Abstract][Full Text] [Related]
14. A20 is a master switch of IL-33 signaling in macrophages and determines IL-33-induced lung immunity.
Holgado A; Liu Z; Aidarova A; Mueller C; Haegman M; Driege Y; Kreike M; Scott CL; Afonina IS; Beyaert R
J Allergy Clin Immunol; 2023 Jul; 152(1):244-256.e4. PubMed ID: 36898482
[TBL] [Abstract][Full Text] [Related]
15. Dietary Fiber-Induced Microbial Short Chain Fatty Acids Suppress ILC2-Dependent Airway Inflammation.
Lewis G; Wang B; Shafiei Jahani P; Hurrell BP; Banie H; Aleman Muench GR; Maazi H; Helou DG; Howard E; Galle-Treger L; Lo R; Santosh S; Baltus A; Bongers G; San-Mateo L; Gilliland FD; Rehan VK; Soroosh P; Akbari O
Front Immunol; 2019; 10():2051. PubMed ID: 31620118
[TBL] [Abstract][Full Text] [Related]
16. Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma.
Ju X; Nagashima A; Dvorkin-Gheva A; Wattie J; Howie K; Whetstone C; Ranjbar M; Cusack R; Ditta R; Paré G; Satia I; O'Byrne PM; Gauvreau GM; Sehmi R
Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38598774
[TBL] [Abstract][Full Text] [Related]
17. Alternative activation generates IL-10 producing type 2 innate lymphoid cells.
Seehus CR; Kadavallore A; Torre B; Yeckes AR; Wang Y; Tang J; Kaye J
Nat Commun; 2017 Dec; 8(1):1900. PubMed ID: 29196657
[TBL] [Abstract][Full Text] [Related]
18. Female-specific enhancement of eosinophil recruitment and activation in a type 2 innate inflammation model in the lung.
Karkout R; Gaudreault V; Labrie L; Aldossary H; Azalde Garcia N; Shan J; Fixman ED
Clin Exp Immunol; 2024 Mar; 216(1):13-24. PubMed ID: 37607041
[TBL] [Abstract][Full Text] [Related]
19. TNF Superfamily and ILC2 Activation in Asthma.
Matsuyama T; Salter BM; Emami Fard N; Machida K; Sehmi R
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540714
[TBL] [Abstract][Full Text] [Related]
20. Orai inhibition modulates pulmonary ILC2 metabolism and alleviates airway hyperreactivity in murine and humanized models.
Howard E; Hurrell BP; Helou DG; Shafiei-Jahani P; Hasiakos S; Painter J; Srikanth S; Gwack Y; Akbari O
Nat Commun; 2023 Sep; 14(1):5989. PubMed ID: 37752127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
